EUROMACS-RHF Score for Right Heart Failure after LVAD
Predicts right heart failure (RHF) after left ventricular assist device (LVAD) implantation. Identifies patients at high risk who may benefit from RVAD or early optimisation.
Score interpretation
→ EUROMACS-RHF Low Risk (0–2): Low risk of right heart failure post-LVAD. Proceed with standard LVAD protocol. Post-op RV assessment and optimisation.
→ EUROMACS-RHF Intermediate Risk (3–4): Moderate RHF risk. Consider preoperative RV optimisation (milrinone, inhaled nitric oxide). Plan for prophylactic RVAD placement if clinical deterioration. LVAD centre MDT review.
→ EUROMACS-RHF High Risk (≥5): High risk of RHF. Consider alternative therapies (cardiac transplant); prophylactic RVAD or BiVAD; inhaled nitric oxide perioperatively; intensive post-op RV management in cardiac ICU.
Interpretation bands for the EUROMACS-RHF. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.